The yeast cadmium factor (YCF1) gene encodes an MgATP-energized glutathione S-conjugate transporter responsible for the vacuolar sequestration of organic compounds after their S-conjugation with glutathione. However, while YCF1 was originally isolated according to its ability to confer resistance to cadmium salts, neither its mode of interaction with Cd 2؉ nor the relationship between this process and organic glutathione-conjugate transport are known. Here we show through direct comparisons between vacuolar membrane vesicles purified from Saccharomyces cerevisiae strain DTY167, harboring a deletion of the YCF1 gene, and the isogenic wild-type strain DTY165 that YCF1 mediates the MgATP-energized vacuolar accumulation of Cd⅐glutathione complexes. The substrate requirements, kinetics and Cd 2؉ ͞ glutathione stoichiometry of cadmium uptake and the molecular weight of the transport-active complex demonstrate that YCF1 selectively catalyzes the transport of bis(glutathionato)cadmium (Cd⅐GS 2 ). On the basis of these results-the Cd 2؉ hypersensitivity of DTY167, versus DTY165, cells, the inducibility of YCF1-mediated transport, and the rapidity and spontaneity of Cd⅐GS 2 formation-this new pathway is concluded to contribute substantially to Cd 2؉ detoxification.
A new class of ATP-binding cassette (ABC) transporter responsible for MgATP-energized transport of organic compounds after their conjugation with glutathione (GSH) has recently been discovered. Formerly designated the GS-X pump (1), this transporter, or family of transporters, has been implicated in the extrusion of a broad range of S-conjugated compounds from the cytosol.
To date, two closely related GS-X pumps have been identified molecularly. These are the human multidrug resistanceassociated protein (MRP1) (2, 3) and the yeast cadmium factor (YCF1) protein (4, 5) . MRP1 and YCF1 are 43% identical (63% similar) at the amino acid level, possess nucleotide binding folds with an equivalent spacing of conserved residues, and contain two subclass-specific structures, a central truncated cystic fibrosis transmembrane conductance regulatorlike ''regulatory'' domain, rich in charged amino acids, and an Ϸ200-amino acid residue N-terminal extension (2, 4) . MRP1 catalyzes the MgATP-energized transport of leukotriene C 4 and related GSH S-conjugates (GS-conjugates) across the plasma membrane of mammalian cells (3, 6, 7) . YCF1 catalyzes the transport of organic GS-conjugates into the vacuole of Saccharomyces cerevisiae (5) .
Given the participation of both of these integral membrane proteins in the transport of organic GS-conjugates and their implied role in the elimination and͞or sequestration of cytotoxic drugs, it is intriguing that the YCF1 gene was initially identified by screening a yeast genomic library for the ability of multicopy DNA fragments to confer resistance to cadmium salts in the growth medium (4) . The question of how the vacuolar sequestration of organic GS-conjugates by YCF1 is related to Cd 2ϩ resistance therefore arises. Specifically, is the detoxification of Cd 2ϩ by YCF1 dependent on its interaction with GSH, as is the case for organic xenobiotics (5) and, if so, how does GSH exert its effects?
In this communication we address these questions to show that YCF1 is not only competent in the MgATP-energized transport of organic GS-conjugates but also Cd 2ϩ after its complexation with GSH. Our findings demonstrate a new pathway for the vacuolar sequestration of Cd 2ϩ in S. cerevisiae: YCF1-mediated transport of bis(glutathionato)cadmium (Cd⅐GS 2 ).
MATERIALS AND METHODS
Yeast Strains. The two strains of S. cerevisiae used in these studies-DTY165 (MAT␣ ura3-52 his6 leu2-3,-112 his3-⌬200 trp1-901 lys2-801 suc2-⌬) and the isogenic ycf1⌬ mutant strain, DTY167 (MAT␣ ura3-52 his6 leu2-3,-112 his3-⌬200 trp1-901 lys2-801 suc2-⌬, ycf1::hisG)-were manipulated as described (5, 8) .
Isolation of Vacuolar Membrane Vesicles. Vacuolar membrane vesicles were prepared as described (5) , except that the dithiothreitol (1 mM) and EGTA (1 mM) present in the standard membrane isolation medium (5, 9) were removed to prevent the attenuation of YCF1-dependent Cd 2ϩ transport otherwise exerted by these compounds (see Discussion). Vesiculated vacuolar membranes were subjected to three cycles of 50-fold dilution into simplified suspension medium (1.1 M glycerol͞5 mM Tris⅐Mes, pH 8.0), centrifugation at 100,000 ϫ g for 35 min, and resuspension in the same medium before use.
Purification of Cadmium⅐Glutathione Complexes. Singly radiolabeled 109 Cd⅐GS n and doubly radiolabeled 109 Cd⅐[ 3 H]GS n complexes were prepared by sequential gelfiltration and anion-exchange chromatography of the reaction products generated by incubating 20 mM 109 CdSO 4 (78.4 mCi͞mmol; 1 Ci ϭ 37 GBq) with 40 mM GSH or 40 mM [ 3 H]GSH (240 mCi͞mmol) in 15 ml 10 mM phosphate buffer (pH 8.0) containing 150 mM KNO 3 at 45ЊC for 24 h. For gel-filtration, 2 ml aliquots of the reaction mixture were applied to a column (40 ϫ 1.5 cm interior diameter) packed with water-equilibrated Sephadex G-15, eluted with deionized water, and 109 Cd and͞or 3 H in the fractions was measured by liquid scintillation counting. The fractions encompassed by each of the two 109 Cd⅐GS n peaks identified were pooled, lyophilized, and redissolved in 4 ml of loading buffer (5 mM Tris⅐Mes, pH 8.0). For anion-exchange chromatography, 0.5 ml aliquots of the resuspended lyophilizates from gel-filtration chromatography were applied to a Mono-Q HR5 ͞5 column (Pharmacia) equilibrated with the same buffer. Elution was with a linear gradient of NaCl (0.5 ml ͞min; 0-500 mM) dissolved in loading buffer. The individual fractions corresponding to the major peaks of 109 Cd obtained from the Mono-Q column (one each for the peaks resolved by gelfiltration chromatography) were pooled, lyophilized, and resuspended in 4 ml deionized water after liquid scintillation counting. Buffer salts were removed before transport measurements or mass spectrometry by passing the samples down a column (120 ϫ 1.0 cm interior diameter) packed with water-equilibrated Sephadex G-15. 3 H-labeled purified Cd⅐GS n complexes as described (5) except that the wash media contained 100 M CdSO 4 in addition to sorbitol (400 mM) and Tris⅐Mes (3 mM, pH 8.0).
Pretreatment of DTY165 Cells with Cd 2؉ or 1-Chloro-2,4-Dinitrobenzene (CDNB). For studies of the inducibility of YCF1 expression and YCF1-dependent transport, DTY165 cells were grown in yeast extract͞peptone͞dextrose (YPD) medium (8) for 24 h at 30ЊC to an OD 600 of 1.0-1.2, pelleted by centrifugation and resuspended in fresh YPD medium containing CdSO 4 (200 M) or CDNB (150 M). After washing in distilled water, total RNA was extracted and vacuolar membrane vesicles were prepared from the pretreated cells. Control RNA and membrane samples were prepared from DTY165 cells treated in an identical manner except that CdSO 4 and CDNB were omitted from the second incubation cycle.
RNase Protection Assays. Cd 2ϩ and CDNB-elicited increases in YCF1 mRNA levels were assayed by RNase protection using 18S rRNA as an internal control. YCF1-specific probe was generated by PCR amplification of the full-length YCF1::HA gene, encoding human influenza hemagglutinin 12CA5 (H A) epitope-tagged YCF1, using plasmid pYCF1-HA (5) as template. The forward, YCF1-specific, primer and backward primer, containing the HA-tag coding sequence, had the sequences 5Ј-AAACTCGAGATGGCTG-GTAATCTTGTTTC-3Ј and 5Ј-GCCTCTAGATCAAGCG-TAGTCTGGGACGTCGTATGGGTA AT T T TCAT-TGA-3Ј, respectively. 18S rRNA-specific probe was synthesized by PCR of S. cerevisiae genomic DNA using sense and antisense primers with the sequences 5Ј-AGATTAAGCCAT-GCATGTCT-3Ј and 5Ј-TGCTGGTACCAGACT TGC-CCTCC-3Ј, respectively. Both PCR products were individually subcloned into pCRII vector (Invitrogen) to generate plasmids pCR-YCF1 and pCR-Y18S. After linearization of pCR-YCF1 and pCR-Y18S with AflI and NcoI, a 320-nucleotide YCF1-specific RNA probe and 220-nucleotide 18S rRNA-specific probe were synthesized using T7 RNA polymerase and SP6 RNA polymerase, respectively. Aliquots of total RNA, prepared as described (10), from control, CdSO 4 -, or CDNBpretreated DTY165 cells were hybridized with a mixture of 32 P-labeled YCF1 antisense probe (1 ϫ 10 6 cpm) and 18S rRNA antisense probe (5 ϫ 10 2 cpm), and RNase protection (11) was assayed using an RPAII kit (Ambion).
Matrix-Assisted Laser Desorption Mass Spectrometry (MALD-MS).
The 109 Cd⅐GS n complexes purified by gelfiltration and anion-exchange chromatography were adjusted to a final concentration of 2-5 mM (as Cd) with deionized water, mixed with an equal volume of sinapinic acid (10 mg͞ml) dissolved in acetonitrile͞H 2 O͞trifluoroacetic acid (70:30:0.1%, vol͞vol) and applied to the ion source of a PerSeptive Biosystems (Cambridge, MA) Voyager RP Biospectrometry Workstation. The instrument, which was equipped with a 1.3-m flight tube and variable two-stage ion source set at 30 kV, was operated in linear mode. Mass͞charge (m͞z) ratio was measured by time-of-flight after calibration with external standards.
Protein Assays. Protein was estimated by a modification of the method of Peterson (12) . 
RESULTS

ycf1⌬ Mutants Are Defective in GSH-Dependent Cd
2؉
Transport. Physiological (1 mM) concentrations of GSH (13) promoted Cd 2ϩ uptake by vacuolar membrane vesicles purified from the wild-type strain DTY165 but not the ycf1⌬ mutant strain DTY167 (Fig. 1) . Addition of Cd 2ϩ (80 M) to GSHcontaining media elicited MgATP-dependent, uncouplerinsensitive 109 Cd 2ϩ uptake rates of 4.5 and 0.8 nmol͞mg per min by DTY165 and DTY167 membranes, respectively ( Fig. 1  A and B) . Uptake by DTY165 membranes was diminished more than 9-fold by the omission of GSH (Fig. 1 A) whereas uptake by DTY167 membranes was slightly stimulated (Fig.  1B) .
GSH maximally stimulated uptake within minutes (t1 ͞2 Ͻ 5 min) of the addition of Cd 2ϩ to the uptake medium (data not shown) and uptake was sigmoidally dependent on Cd 2ϩ concentration, achieving half-maximal velocity at 120 M (Fig.  1C) .
Specific Requirement for GSH. The stimulatory action of GSH was abolished by the omission of MgATP from the assay medium ( Fig. 1 and Table 1) , and 1 mM concentrations of oxidized GSH (GSSG), S-methylglutathione, cysteinylglycine, cysteine, or glutamate did not promote MgATP-dependent, uncoupler-insensitive Cd 2ϩ uptake by vacuolar membrane vesicles from either strain ( Table 1) .
Purification of Transport-Active Complex. To determine the mode of action of GSH and the form in which Cd 2ϩ is transported, reaction mixtures initially containing Cd 2ϩ and GSH were fractionated and YCF1-dependent uptake was assayed.
Incubation of 109 Cd 2ϩ with GSH and gel-filtration of the mixture on Sephadex G-15 yielded two major 109 Cd-labeled peaks: a low molecular weight peak [LMW-mono(glutathionato)cadium (Cd⅐GS)] and a high molecular weight peak (HMW-Cd⅐GS) ( Fig. 2A) . When rechromatographed on Mono-Q, LMW-Cd⅐GS and HMW-Cd⅐GS eluted at 0 (Fig. 2C ) and 275 mM NaCl, respectively (Fig. 2B) (Table 2 ). (iii) The principal ion peak detected after MALD-MS of HMW-Cd⅐GS had an m͞z ratio of 725.4 Ϯ 0.7, consistent with the molecular weight of Cd⅐GS 2 (724.6 Da, Fig. 4) . The transport-inactive complex, LMWCd⅐GS, on the other hand, was tentatively identified as Cd⅐GS on the basis of its smaller apparent molecular size (Fig. 2 A) , failure to bind Mono-Q (Fig. 2C) , and Cd͞GS ratio of 0.67 Ϯ 0.04 and 0.86 Ϯ 0.07 after chromatography on Sephadex G-15 and Mono-Q (Table 2) , respectively.
While an m͞z ratio of 725 for HMW-Cd⅐GS would be equally compatible with the transport of Cd⅐GSSG, this is refuted by two findings: (i) GSSG, alone, does not promote YCF1-dependent uptake (Table 1) , and (ii) the transport-active complex is probably a mercaptide. Pretreatment of HMWCd⅐GS with 2-mercaptoethanol inhibits MgATP-dependent, uncoupler-insensitive Cd 2ϩ uptake by DTY165 membranes by more then 80% (Table 2) , and S-methylation abolishes the stimulatory action of GSH (Table 1) . GSH, oxidized glutathione (GSSG), S-methylglutathione (GS-CH3), cysteinylglycine, cysteine, and glutamate were added at concentrations of 1 mM. MgATP, 109 CdSO4, and gramicidin-D were added at concentrations of 3 mM, 80 M, and 5 M, respectively. Values shown are means Ϯ SE (n ϭ 3-6). dependent transport to be examined directly and confirmed that more than 83% of the MgATP-dependent, uncouplerinsensitive Cd 2ϩ transport measured using DTY165 membranes was mediated by YCF1. Agents that dissipate both the ⌬pH and ⌬ components of the H ϩ -electrochemical gradient established by the vacuolar H ϩ -ATPase [V-ATPase; carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP), gramicidin-D] or directly inhibit the V-ATPase, itself (bafilomycin A 1 ), decreased MgATP-dependent Cd⅐GS 2 uptake by vacuolar membrane vesicles from DTY165 cells by 22% (Table 3) . Ammonium chloride, which abolishes ⌬pH while leaving ⌬ unaffected, on the other hand, inhibited uptake by only 15% (Table 3) . From these results and the inability of uncouplers to markedly increase the inhibitions caused by V-ATPase inhibitors, alone (Table 3) , Cd⅐GS 2 uptake by wild-type membranes is inferred to proceed via a YCF1-dependent, MgATPenergized pathway that accounts for most of the transport measured and a YCF1-independent pathway, primarily driven by the H ϩ -gradient established by the V-ATPase, that makes a minor contribution to total uptake. The same pretreatments increased MgATP-dependent, uncoupler-insensitive 109 Cd⅐GS 2 uptake into vacuolar membrane vesicles by 1.4-and 1.7-fold and [ 3 H]DNP-GS uptake by 1.6-and 2.8-fold (Fig. 5 ).
DISCUSSION
These investigations provide an indication of the mechanism by which YCF1 confers Cd 2ϩ resistance in S. cerevisiae and its relationship to the transport of organic GS-conjugates by demonstrating that the integral membrane protein encoded by this gene specifically catalyzes the MgATP-energized uptake of Cd⅐GS 2 by vacuolar membrane vesicles. The codependence of Cd⅐GS 2 and organic GS-conjugate transport on YCF1 is evident at multiple levels. (i) The ycf1⌬ mutant strain, DTY167, is hypersensitive to Cd 2ϩ and CDNB in the growth medium, and both hypersensitivities are alleviated by transformation with plasmid-borne YCF1 (4, 5) . (ii) Vacuolar membrane vesicles purified from DTY167 cells are grossly impaired for MgATP-energized, uncoupler-insensitive organic GS-conjugate and GSH-promoted Cd 2ϩ uptake. (iii) (5) by showing that YCF1 is a vacuolar GS-conjugate transporter, and gone on to demonstrate that transformation with human MRP1 suppresses the ycf1⌬ mutation, their results differ from ours in their inability to detect MgATP-energized, GSH-dependent Cd 2ϩ uptake by microsomes from MRP1-transformed yeast. Because of this and their failure to inhibit DNP-GS transport by the inclusion of GSH (1 mM) and Cd 2ϩ (100-300 M) in the uptake medium, these authors attribute the Cd 2ϩ resistance conferred by MRP1 to a two-phase process: the initial transport of Cd 2ϩ into the vacuole by H ϩ ͞Cd 2ϩ antiport and its subsequent complexation with an unknown binding molecule transported by MRP1. Two alternative conclusions therefore follow. Either MRP1 and YCF1 do not have precisely the same transport mechanism or Tommasini et al.'s inability to measure GSH-promoted Cd 2ϩ transport has a methodological basis. Of these, the second explanation is the more likely. First, the idea that MRP1 and YCF1 use identical mechanisms for the uptake of organic GS-conjugates but different mechanisms for Cd 2ϩ seems unnecessarily complicated when both transporters must encounter the same microenvironment in yeast. Second, the twophase mechanism does not explain how MRP1 phenocopies YCF1 and how DNP-GS inhibits YCF1-dependent Cd⅐GS 2 transport in a simple competitive manner. Third, inspection of the procedures employed by Tommasini et al (18) -methods originally developed in our laboratory for a different purpose (9)-reveals a critical technical error: systematic contamination of the Cd 2ϩ uptake media with approximately 140 M concentrations of dithiothreitol and EDTA. We know from preliminary experiments that these concentrations are more than sufficient to cause a near total abolition of GSHdependent Cd 2ϩ uptake by YCF1 while leaving organic GSconjugate uptake unaffected. Dithiothreitol reacts with Cd 2ϩ to form a transport-inactive dimercaptide (Z.-S.L. and P.A.R., unpublished results); EDTA chelates free Cd 2ϩ to quench its reaction with GSH.
Further verification of the one-phase model is provided by the functional equivalence of YCF1 to MRP1 in all other regards. At the biochemical level, YCF1 specifically catalyzes the transport of Cd⅐GS 2 . This is the most straightforward explanation of the mass and 1:2 Cd͞GS ratio of the transportactive complex and the finding that the concentrationdependence of uptake assumes a Michaelian, rather than sigmoidal, function with a moderately low K m when Cd⅐GS 2 is purified from the other components present in a mixture of Cd 2ϩ and GSH. Analogously, MRP1 catalyzes the transport of bis(glutathionato)platinum (Pt⅐GS 2 ) (19) . MALD-MS and 1 H-NMR spectroscopy of the transport-active complex formed when the anticancer drug, cisplatin, is combined with GSH indicate that Pt spontaneously complexes with GSH in a 1:2 ratio. Two GSH molecules coordinate each Pt 2ϩ ion via their cysteinyl sulfur and amino nitrogen atoms to generate the transport-active complex. At the cellular level, YCF1 and MRP1 confer resistance to and are induced by a similar spectrum of xenobiotics. YCF1 confers cross-resistance to organic xenobiotics and heavy metals (4, 5). Enhanced expression of MRP1 in mammalian cells is associated with cross- resistance to cisplatin and heavy metals, such as cadmium and arsenite, as well as GSH-conjugable drugs (7, 20) . Expression of YCF1 is increased by exposure of cells to GSH-conjugable xenobiotics and Cd 2ϩ . Expression of MRP1 is increased by exposure of cells to arsenite, Cd 2ϩ and Zn 2ϩ (20) . The existence of phytochelatins (PCs), peptides consisting of repeating units of ␥-glutamylcysteine followed by a Cterminal glycine [(␥-Glu-Cys) n -Gly], in the fission yeast, Schizosaccharomyces pombe (21) and the isolation and characterization of the heavy metal tolerance (HMT1) gene, a six transmembrane span-single nucleotide binding fold (''single half'') ATP binding cassette (ABC) transporter, responsible for vacuolar uptake of PC and Cd⅐PC, from the same organism (21, 22) , prompts two related questions. Do similar mechanisms of Cd 2ϩ sequestration operate in S. cerevisiae? Is YCF1 competent in the transport of Cd⅐PC as well as Cd⅐GS 2 ? The first question has not been resolved but PCs are more widespread in fungi than was once thought. Although heavy metal detoxification in fungi has been largely attributed to metallothioneins (23) , recent studies of Candida glabrata, S. cerevisiae, and Neurospora crassa also implicate PCs. Exposure of C. glabrata to copper salts stimulates metallothionein formation but exposure to cadmium salts stimulates PC formation (24) . In both S. cerevisiae and N. crassa, PCs have been detected and in the latter synthesis is not only activated by Cd 2ϩ but also Zn 2ϩ (25) . Interestingly, in all three organisms, PC 2 is the dominant PC species found. Hence, the second question or a modification thereof. Given the structural resemblance between Cd⅐PC 2 [Cd⅐(␥-Glu-Cys) 2 -Gly] and Cd⅐GS 2 , might YCF1 be able to transport either complex? The answer to this question is no: YCF1 does not transport PC 2 . PC 2 fractions purified from S. pombe show no evidence of YCF1-dependent transport by vacuolar membrane vesicles isolated from S. cerevisiae irrespective of whether the PC preparations are complexed with Cd 2ϩ or not (Z.-S.L. and P.A.R., unpublished results). The novelty of YCF1-mediated Cd⅐GS 2 transport as a mechanism for the vacuolar sequestration of Cd 2ϩ is therefore substantiated.
